Inhibiting the Keap1/Nrf2 Protein‐Protein Interaction with Protein‐Like Polymers
Advanced Materials · 2024
DOI: 10.1002/adma.202311467 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, 2024. Verfasst von Kendal P Carrow und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, McCormick School of Engineering, Medical Scientist Training Program, Feinberg School of Medicine, International…. Hauptthemen laut MEDLINE: Kelch-Like ECH-Associated Protein 1, NF-E2-Related Factor 2, Polymers, Protein Binding. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Science Foundation, NIH HHS, NHLBI NIH HHS.
Abstract (Originalsprache)
Successful and selective inhibition of the cytosolic protein‐protein interaction (PPI) between nuclear factor erythroid 2‐related factor 2 (Nrf2) and Kelch‐like ECH‐associating protein 1 (Keap1) can enhance the antioxidant response, with the potential for a therapeutic effect in a range of settings including in neurodegenerative disease (ND). Small molecule inhibitors have been developed, yet many have off‐target effects, or are otherwise limited by poor cellular permeability. Peptide‐based strategies have also been attempted to enhance specificity, yet face challenges due to susceptibility to degradation and lack of cellular penetration. Herein, these barriers are overcome utilizing a polymer‐based proteomimetics. The protein‐like polymer (PLP) consists of a synthetic, lipophilic polymer backbone displaying water soluble Keap1‐binding peptides on each monomer unit forming a brush polymer architecture. The PLPs are capable of engaging Keap1 and displacing the cellular protective transcription factor Nrf2, which then translocates to the nucleus, activating the antioxidant response element (ARE). PLPs exhibit increased Keap1 binding affinity by several orders of magnitude compared to free peptides, maintain serum stability, are cell‐penetrant, and selectively activate the ARE pathway in cells, including in primary cortical neuronal cultures. Keap1/Nrf2‐inhibitory PLPs have the potential to impact the treatment of disease states associated with dysregulation of oxidative stress, such as NDs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Engineering, McCormick School of Engineering, Medical Scientist Training Program, Feinberg School of Medicine, International Institute for Nanotechnology, Northwestern University, Evanston, 6020…
- School of Pharmacy, University of Wisconsin, Madison, 57305, WI, USA.
- International Institute for Nanotechnology, Department of Chemistry, Chemistry of Life Processes Institute, Northwestern University, Evanston, 60208, IL, USA.
- Department of Chemical and Biological Engineering, McCormick School of Engineering, Northwestern University, Evanston, 60208, IL, USA.
- Department of Natural Sciences, Baruch College, City University of New York, New York, 10010, NY, USA.
- Center for Systems Biology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
ORCID-Profile: Kendal P Carrow, Haylee L Hamilton, Madeline P Hopps, Yang Li, Baofu Qiao, N Connor Payne, Matthew P Thompson, Xiaoyu Zhang, Assa Magassa, Mara Fattah, Shivangi Agarwal, Michael P Vincent, Marina Buyanova, Paul A Bertin, Ralph Mazitschek, Monica Olvera de la Cruz, Delinda A Johnson, Jeffrey A Johnson, Nathan C Gianneschi
Förderung
- National Science Foundation
- NIH HHS
- NHLBI NIH HHS
- NCI NIH HHS
- International Institute for Nanotechnology, Northwestern University
- NIGMS NIH HHS
- NIA NIH HHS
- Damon Runyon Cancer Research Foundation
Zitieren
APA
Carrow, K. P., Hamilton, H. L., Hopps, M. P., Li, Y., Qiao, B., Payne, N. C., Thompson, M. P., Zhang, X., Magassa, A., Fattah, M., Agarwal, S., Vincent, M. P., Buyanova, M., Bertin, P. A., Mazitschek, R., Olvera de la Cruz, M., Johnson, D. A., Johnson, J. A., & Gianneschi, N. C. (2024). Inhibiting the Keap1/Nrf2 Protein‐Protein Interaction with Protein‐Like Polymers. Advanced Materials. https://doi.org/10.1002/adma.202311467
Vancouver
Carrow KP, Hamilton HL, Hopps MP, Li Y, Qiao B, Payne NC, et al. Inhibiting the Keap1/Nrf2 Protein‐Protein Interaction with Protein‐Like Polymers. Advanced Materials. 2024. doi:10.1002/adma.202311467
BibTeX
@article{Carrow2024,
author = {Carrow, Kendal P and Hamilton, Haylee L and Hopps, Madeline P and Li, Yang and Qiao, Baofu and Payne, N Connor and Thompson, Matthew P and Zhang, Xiaoyu and Magassa, Assa and Fattah, Mara and Agarwal, Shivangi and Vincent, Michael P and Buyanova, Marina and Bertin, Paul A and Mazitschek, Ralph and Olvera de la Cruz, Monica and Johnson, Delinda A and Johnson, Jeffrey A and Gianneschi, Nathan C},
title = {Inhibiting the Keap1/Nrf2 Protein‐Protein Interaction with Protein‐Like Polymers},
journal = {Advanced Materials},
year = {2024},
doi = {10.1002/adma.202311467}
}
EUVIMED